Loading insider details...
Beta
Latest Form 4 (May 28, 2026): Grant/Award of 8,000 VIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Jun 2, 2025 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Jun 3, 2024 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| May 24, 2023 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 6,027 | n/a |
| May 25, 2022 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 6,405 | n/a |
| May 25, 2021 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 3,374 | n/a |
| Feb 8, 2021 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 25,000 | n/a |
| Dec 11, 2020 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 46,500 | n/a |
| May 22, 2020 | MIRAGEN THERAPEUTICS, INC. (MGEN) | Grant/Award | 24,000 | n/a |
| May 8, 2020 | aTYR PHARMA INC (LIFE) | Grant/Award | 1,428 | n/a |